Records 1 - 6
| Polymorphisms of FDPS, LRP5, SOST and VKORC1 genes and their relation with osteoporosis in postmenopausal Romanian women.
PloS one 2019 14 (11): e0225776.
Ciubean Alina Deniza, Ungur Rodica Ana, Irsay Laszlo, Ciortea Viorela Mihaela, Borda Ileana Monica, Dogaru Gabriela Bombonica, Trifa Adrian Pavel, Vesa Stefan Cristian, Buzoianu Anca Da
| Genetic and acquired factors influencing the effectiveness and toxicity of drug therapy in osteoporosis.
Expert opinion on drug metabolism & toxicology 2016 Feb .
López-Delgado Laura, Riancho-Zarrabeitia Leyre, Riancho José
| Association of farnesyl diphosphate synthase polymorphisms and response to alendronate treatment in Chinese postmenopausal women with osteoporosis.
Chinese medical journal 2014 127 (4): 662-8.
Liu Yi, Liu Haijuan, Li Mei, Zhou Peiran, Xing Xiaoping, Xia Weibo, Zhang Zhenlin, Liao Eryuan, Chen Decai, Liu Jian, Tao Tianzun, Wu Wen, Xu Li
| Effects of differences in polymorphism of gene encoding enzyme faenesyl diphosphate synthase (FDPS), rs2297480, on bone mineral density and biochemical markers of bone turnover in Thai postmenopausal women.
Journal of the Medical Association of Thailand = Chotmaihet thangphaet 2011 Oct 94 Suppl 5 S38-46.
Songpatanasilp Thawee, Chanprasertyothin Suwann
| Genetic polymorphism of geranylgeranyl diphosphate synthase (GGSP1) predicts bone density response to bisphosphonate therapy in Korean women.
Yonsei medical journal 2010 Mar 51 (2): 231-8.
Choi Hyung Jin, Choi Ji Yeob, Cho Sun Wook, Kang Daehee, Han Ki Ok, Kim Sang Wan, Kim Seong Yeon, Chung Yoon-Sok, Shin Chan S
| Modulatory effect of farnesyl pyrophosphate synthase (FDPS) rs2297480 polymorphism on the response to long-term amino-bisphosphonate treatment in postmenopausal osteoporosis.
Current medical research and opinion 2008 Sep 24 (9): 2609-15.
Marini Francesca, Falchetti Alberto, Silvestri Sandra, Bagger Yu, Luzi Ettore, Tanini Annalisa, Christiansen Claus, Brandi Maria Lui